胱抑素 C 最新进展：临床应用。
Update on cystatin C: incorporation into clinical practice.
机构信息
San Francisco VA Medical Center, San Francisco, CA 94121, USA.
出版信息
Am J Kidney Dis. 2013 Sep;62(3):595-603. doi: 10.1053/j.ajkd.2013.03.027. Epub 2013 May 20.
Abstract
Kidney function monitoring using creatinine-based glomerular filtration rate estimation is a routine part of clinical practice. Emerging evidence has shown that cystatin C may improve classification of glomerular filtration rate for defining chronic kidney disease in certain clinical populations and assist in understanding the complications of chronic kidney disease. In this review and update, we summarize the overall literature on cystatin C, critically evaluate recent high-impact studies, highlight the role of cystatin C in recent kidney disease guidelines, and suggest a practical approach for clinicians to incorporate cystatin C into practice. We conclude by addressing frequently asked questions related to implementing cystatin C use in a clinical setting.
摘要
使用基于肌酐的肾小球滤过率估计进行肾功能监测是临床实践的常规部分。新出现的证据表明，胱抑素 C 可能会改善某些临床人群中肾小球滤过率的分类，以定义慢性肾脏病，并有助于了解慢性肾脏病的并发症。在本次综述和更新中，我们总结了胱抑素 C 的总体文献，批判性地评估了最近的高影响力研究，强调了胱抑素 C 在最近的肾脏病指南中的作用，并为临床医生提出了将胱抑素 C 纳入实践的实用方法。最后，我们回答了与在临床环境中实施胱抑素 C 使用相关的常见问题。
相似文献
1
Update on cystatin C: incorporation into clinical practice.胱抑素 C 最新进展：临床应用。
Am J Kidney Dis. 2013 Sep;62(3):595-603. doi: 10.1053/j.ajkd.2013.03.027. Epub 2013 May 20.
2
Cystatin C as a biomarker for estimating glomerular filtration rate.胱抑素C作为评估肾小球滤过率的生物标志物。
Curr Opin Nephrol Hypertens. 2015 May;24(3):295-300. doi: 10.1097/MNH.0000000000000115.
3
Cystatin C-based glomerular filtration rate estimating equations in early chronic kidney disease.早期慢性肾脏病中基于胱抑素C的肾小球滤过率估算方程
Indian Pediatr. 2014 Apr;51(4):273-7. doi: 10.1007/s13312-014-0400-5.
4
Estimation of Glomerular Filtration Rate in Elderly Chronic Kidney Disease Patients: Comparison of Three Novel Sophisticated Equations and Simple Cystatin C Equation.老年慢性肾脏病患者肾小球滤过率的估算：三种新型复杂方程与简单胱抑素C方程的比较
Ther Apher Dial. 2017 Apr;21(2):126-132. doi: 10.1111/1744-9987.12523. Epub 2017 Mar 10.
5
Is combined cystatin C and creatinine based equation better in predicting GFR?基于胱抑素C和肌酐的联合方程在预测肾小球滤过率方面是否更优？
Indian Pediatr. 2014 Apr;51(4):262-3.
6
Combining Cystatin C and Creatinine Yields a Reliable Glomerular Filtration Rate Estimation in Older Adults in Contrast to β-Trace Protein and β2-Microglobulin.与β-微量蛋白和β2-微球蛋白相比，联合使用胱抑素C和肌酐可更可靠地估算老年人的肾小球滤过率。
Nephron. 2017;137(1):29-37. doi: 10.1159/000473703. Epub 2017 Apr 14.
7
Measurement and Estimation of Glomerular Filtration Rate in Children.儿童肾小球滤过率的测量与估算
Adv Chronic Kidney Dis. 2017 Nov;24(6):348-356. doi: 10.1053/j.ackd.2017.09.011.
8
Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients.胱抑素 C 与肌酐估算肾功能：对急性住院老年患者药物处方的影响。
Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):466-478. doi: 10.1111/bcpt.13156. Epub 2018 Dec 7.
9
Educational review: measurement of GFR in special populations.教育评论：特殊人群的肾小球滤过率测量。
Pediatr Nephrol. 2018 Nov;33(11):2037-2046. doi: 10.1007/s00467-017-3852-8. Epub 2017 Dec 7.
10
[Estimation of glomerular filtration rate using cystatin C].[使用胱抑素C估算肾小球滤过率]
Ann Biol Clin (Paris). 2019 Aug 1;77(4):375-380. doi: 10.1684/abc.2019.1456.
引用本文的文献
1
Feasibility of replacing Tc-DTPA GFR measurements with eGFR from cystatin C in individuals with spinal cord injuries.在脊髓损伤患者中用胱抑素C估算的肾小球滤过率（eGFR）替代锝-二乙三胺五乙酸（Tc-DTPA）肾小球滤过率（GFR）测量的可行性。
Physiol Rep. 2025 May;13(9):e70315. doi: 10.14814/phy2.70315.
2
ICU 'Magic Numbers': The Role of Biomarkers in Supporting Clinical Decision-Making.重症监护病房的“神奇数字”：生物标志物在支持临床决策中的作用
Diagnostics (Basel). 2025 Apr 11;15(8):975. doi: 10.3390/diagnostics15080975.
3
Difference in Cystatin C-Based and Creatinine-Based eGFR and Cognition in Osteoporotic Fracture in Men Study.基于胱抑素C和基于肌酐的估算肾小球滤过率差异与男性骨质疏松性骨折患者认知功能的研究
Kidney360. 2025 Mar 11;6(6):1031-1033. doi: 10.34067/KID.0000000764.
4
Switching to the CKD-EPI but Not Modified FAS eGFR Formula Underdetects CKD Among Adolescents and Young Adults in México.在墨西哥，改用慢性肾脏病流行病学合作组织（CKD-EPI）而非改良的全年龄谱（FAS）估算肾小球滤过率（eGFR）公式会漏诊青少年和青年中的慢性肾脏病。
Children (Basel). 2025 Feb 17;12(2):239. doi: 10.3390/children12020239.
5
Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients.确定危重症患者中基于血清肌酐计算的估计肾小球滤过率与基于胱抑素C计算的估计肾小球滤过率之间的不一致率。
Pharmacotherapy. 2025 Mar;45(3):161-168. doi: 10.1002/phar.70000. Epub 2025 Feb 13.
6
Development and Validation of an Accurate Creatinine-Based Equation to Estimate Glomerular Filtration Rate for the Adult Indian Population: Design and Methods.用于估计成年印度人群肾小球滤过率的基于肌酐的准确方程的开发与验证：设计与方法
Indian J Nephrol. 2024 Sep 18:1-8. doi: 10.25259/IJN_221_2024.
7
Detection of decline in estimated glomerular filtration rate in patients with type 2 diabetes by cystatin C-based equations.基于胱抑素C的公式检测2型糖尿病患者估算肾小球滤过率的下降情况。
World J Nephrol. 2024 Dec 25;13(4):95761. doi: 10.5527/wjn.v13.i4.95761.
8
Association between Proenkephalin A and cardiovascular outcomes in ambulatory Veterans.前脑啡肽A与门诊退伍军人心血管结局之间的关联
Int J Cardiol Heart Vasc. 2024 Nov 16;55:101557. doi: 10.1016/j.ijcha.2024.101557. eCollection 2024 Dec.
9
Comparison of the prevalence and associated factors of chronic kidney disease diagnosed by serum creatinine or cystatin C among young people living with HIV in Uganda.比较乌干达 HIV 感染者中通过血清肌酐或胱抑素 C 诊断的慢性肾脏病的患病率及其相关因素。
BMC Nephrol. 2024 Nov 25;25(1):422. doi: 10.1186/s12882-024-03865-8.
10
Chronic Kidney Disease Progression-A Challenge.慢性肾脏病进展——一项挑战
Biomedicines. 2024 Sep 27;12(10):2203. doi: 10.3390/biomedicines12102203.
本文引用的文献
1
GFR estimation using standardized cystatin C in kidney transplant recipients.采用胱抑素 C 标准化估算肾小球滤过率在肾移植受者中的应用。
Am J Kidney Dis. 2013 Feb;61(2):279-84. doi: 10.1053/j.ajkd.2012.09.010. Epub 2012 Nov 8.
2
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.KDIGO 临床实践指南：糖尿病与慢性肾脏病（2012 年更新版）
Am J Kidney Dis. 2012 Nov;60(5):850-86. doi: 10.1053/j.ajkd.2012.07.005.
3
Two novel equations to estimate kidney function in persons aged 70 years or older.两种估算 70 岁及以上人群肾功能的新方程。
Ann Intern Med. 2012 Oct 2;157(7):471-81. doi: 10.7326/0003-4819-157-7-201210020-00003.
4
Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate.分析和临床验证一种标准化的胱抑素 C 颗粒增强透射比浊法（PETIA）来估计肾小球滤过率。
Clin Chem Lab Med. 2012 Mar 30;50(9):1591-6. doi: 10.1515/cclm-2012-0063.
5
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.胱抑素 C 血清浓度与糖尿病患者终末期肾病的风险。
Diabetes Care. 2012 Nov;35(11):2311-6. doi: 10.2337/dc11-2220. Epub 2012 Jul 30.
6
Serum cystatin C- versus creatinine-based definitions of acute kidney injury following cardiac surgery: a prospective cohort study.血清胱抑素 C 与基于肌酐的心脏手术后急性肾损伤定义：一项前瞻性队列研究。
Am J Kidney Dis. 2012 Dec;60(6):922-9. doi: 10.1053/j.ajkd.2012.06.002. Epub 2012 Jul 17.
7
Estimating glomerular filtration rate from serum creatinine and cystatin C.基于血清肌酐和胱抑素 C 估算肾小球滤过率。
N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248.
8
Cystatin C is a strong predictor of survival in patients with cirrhosis: is a cystatin C-based MELD better?胱抑素 C 是肝硬化患者生存的有力预测因子：基于胱抑素 C 的 MELD 评分是否更好？
Liver Int. 2012 Sep;32(8):1211-6. doi: 10.1111/j.1478-3231.2012.02766.x. Epub 2012 Mar 1.
9
Executive summary: Standards of medical care in diabetes--2012.执行摘要：2012年糖尿病医疗护理标准
Diabetes Care. 2012 Jan;35 Suppl 1(Suppl 1):S4-S10. doi: 10.2337/dc12-s004.
10
Filtration markers may have prognostic value independent of glomerular filtration rate.滤过标志物可能具有独立于肾小球滤过率的预后价值。
J Am Soc Nephrol. 2012 Feb;23(2):351-9. doi: 10.1681/ASN.2011070663. Epub 2011 Dec 15.
Zotero 插件